Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-25
1997-05-13
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546167, 546168, 546116, C07D491048, A61K 31395
Patent
active
056293208
ABSTRACT:
This invention relates to 3-quinolyl-substituted dihydropyridine derivatives, such as ##STR1## or a pharmaceutically acceptable salt thereof. These compounds are used in treating cardiovascular disease.
REFERENCES:
patent: 4145432 (1979-03-01), Sato
patent: 4248873 (1981-02-01), Bossert et al.
patent: 5100900 (1992-03-01), Stoltefuss et al.
patent: 5204472 (1993-04-01), Stoltefuss et al.
P.G. Baraldi, et al., Collect Czech Chem. Commun. "Synthesis and Calcium Antagonist Activity of Dialkyl 1,4-Dimethyl-4-(Nitrogenous Heteroaryl)-3,5-Pyridine Dicarboxylates", vol. 57, pp. 169-178 (1992).
Bechem Martin
Goldmann Siegfried
Gross Rainer
H utter Joachim
Hebisch Siegbert
Bayer Aktiengesellschaft
Springer David B.
LandOfFree
3-quinolyl-substituted dihydropyridines, and their use in medica does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-quinolyl-substituted dihydropyridines, and their use in medica, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-quinolyl-substituted dihydropyridines, and their use in medica will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385585